Stocks
Zynerba Pharmaceuticals (ZYNE) EBITDA US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -39.9 | -34.2 | -52.5 | -36.2 | -34.6 | -38.3 | ||
| Changes by years, y/y, % | +25% | -14% | +54% | -31% | -4% | +1.6% | |||
Zynerba Pharmaceuticals. EBITDA US GAAP, bln rub
Zynerba Pharmaceuticals. EBITDA US GAAP, changes, %
Zynerba Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Zynerba Pharmaceuticals (ZYNE) EBITDA US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -8.34 | -8.01 | -8.95 | -10.3 | -11.0 | -38.3 | |
| Changes by years, y/y, % | -14% | -24% | +2% | +13% | +32% | |||
| Changes by quarters, q/q, % | -9% | -4% | +12% | +15% | +6% | |||
